The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis (Q46132812)
Jump to navigation
Jump to search
scientific article published on 5 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis |
scientific article published on 5 February 2009 |
Statements
1 reference
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis (English)
1 reference
1 reference
Kevin M Pantalone
1 reference
Michael W Kattan
1 reference
Changhong Yu
1 reference
Susana Arrigain
1 reference
Anil Jain
1 reference
Ashish Atreja
1 reference
Robert S Zimmerman
1 reference
5 February 2009
1 reference
1 reference
46
1 reference
2
1 reference
145-154
1 reference